Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 452 for “"Statin"”.
-
Statin-induced muscle mitochondrial toxicity
Statins are the mainstay of cholesterol-lowering therapy and are taken by millions of people worldwide. These drugs are generally well-tolerated but can cause myopathy ranging from mild muscle pain to fatal rhabdomyolysis. The mechanism of statin-induced myopathy (SIM) is not fully understood and …
-
Genetic factors in statin intolerance
… There are approximately 12 million statin users in the United Kingdom. Reports of statin intolerance occurs between 7 and 29% of users, manifesting as muscle ache, fatigue or more seriously, muscle breakdown leading to myopathy. Creatine phosphokinase (CK) levels are used as a …
-
Statin influence on influenza mortality
… pose significant public health threat. Statins are a class of medications traditionally used for atherosclerotic heart disease and elevated cholesterol. Though these medications have been very effective in managing these disease states, there is evidence that the drugs may also have …
-
Statin mediated vasodilation in the vasculature.
… A (HMG-CoA) reductase inhibitors (statins) in lowering cardiovascular morbidity and mortality in patients with and without coronary artery disease. Traditionally, the beneficial effects of statins have been ascribed entirely to their ability to lower serum cholesterol. Evidence …
-
Persistence to statin treatment in lithuania /
… lipoprotein (LDL) lowering medications such as statins play a huge role in the prevention and treatment of cardiovascular diseases. Statins have been shown to have a big impact in reducing the risk of major vascular events and mortality both in primary and secondary prevention. Despite the …
-
Mitochondrial DNA alterations and statin-induced myopathy
Background/Objectives: Statins are widely used to treat hyperlipidemia and lower cardiovascular disease risk. While statins are generally well tolerated, ~10-15% of patients experience statin-induced myopathy (SIM), a potentially fatal complication. Statin treatment has been associated with …
-
Preclinical Potentiators of Statin-induced Anticancer Effects
Statins have been used for decades in the treatment of hypercholesterolemic patients to decrease the incidence of adverse cardiovascular events. Statins target the rate-limiting enzyme of the mevalonate (MVA) pathway, 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR). Statin-mediated HMGCR …
-
Genome-wide association of statin-induced myopathy
<p>Lowering LDL-cholesterol with statin therapy produces substantial reductions in cardiovascular events, and larger cholesterol reductions may produce larger benefits. Rarely, myopathy occurs with statins, especially at higher doses and in combination with certain medications. Similarly strong …
-
Effect of statin treatment on preterm labour
… aim to inhibit these inflammatory pathways. Statins, 5-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, are potent inhibitors of cholesterol biosynthesis, which act on the mevalonate pathway. In addition to their lipid-lowering effects, statins also have anti-inflammatory …
-
Mechanisms underlying statin-induced modulation of ryanodine receptors
<p>Statins, a class of HMG-CoA reductase inhibitors, are amongst the most widely prescribed drugs for the treatment of elevated cholesterol. Despite their success, their use is associated with debilitating muscle side effects such a myopathy, myalgia and in the most serious cases, rhabdomyolysis. …
-
Established Statin Therapy and the Benefits of Niacin
… if the addition of niacin to an established statin therapy would decrease residual cardiovascular risk. Key words used in multiple literature searches included the terms "dyslipidemias, Hydroxymethylglutaryl-CoA Reductase Inhibitors, cardiovascular diseases, niacin, cholesterol HDL, and …
-
POPULATION SOURCED DISCOVERY OF GENETIC VARIANTS IN STATIN METABOLISM
… coenzyme A (HMG-CoA) reductase inhibitors, or statins, are one of the most prescribed drugs for the prevention of cardiovascular disease and act by reducing plasma low-density lipoprotein (LDL) cholesterol. In Singapore, 47% of adult patients use either atorvastatin or simvastatin. Statin …
-
Determinants of Statin Drug Sensitivity in Mevalonate-dependent Cancers
Statins are widely prescribed cholesterol-lowering drugs that inhibit HMG-CoA reductase (HMGCR), the rate-limiting enzyme of the mevalonate pathway. Several lines of evidence support that certain tumours depend on the mevalonate pathway for growth and survival and are vulnerable to statins. …
-
The significance of OATP and CYP450 in statin-flavonoid interactions
Statins are the most prescribed drug world-wide as a first-line defence to hypercholesteraemia. In rare cases, statins can have adverse events such as myotoxicity which can further progress to a potentially fatal condition, rhabdomyolysis. This risk is exacerbated by drug-drug interactions between …
-
Aspirin and Statin Use for Primary Prevention of Cardiovascular Disease
… mortality in the United States and aspirin and statins are well-known medications associated with CVD prevention. There are well-known benefits of aspirin for secondary prevention of CVD, but aspirin’s role in primary prevention remains controversial. The decision to start aspirin for primary …
-
Post-Diagnosis Statin Use and Survival Among Patients with Cancer
Statins are widely used cholesterol-lowering medications. Evidence from preclinical and observational studies suggest that statins use may improve cancer survival in patients with cancer, while findings from clinical trials have been mixed. The aim of this study was to evaluate the association …
-
Body constitution, statin use, and tumor characteristics. Implications for prognosis.
… and to examine the prognostic impact of statin use and body size changes in breast cancer patients. In paper I, we studied the prognostic impact of tumor-specific HMG-CoA reductase (HMGCR), the rate-limiting enzyme of the mevalonate pathway and the target of statin treatment, in breast …
Page 1 of 23